DEO

97.0701.28%
JB

Julie Belita Brown

CFO & Executive Director

Ms. Julie Belita Brown, ACA is Independent Non-Executive Director of Diageo plc from August 5, 2024. Ms. Belita Brown is Chief Financial Officer at GSK plc since May 01, 2023 and serves as its Director since April 03, 2023. She had been the Chief Financial Officer, Chief Operating Officer and Executive Director of Burberry Group Plc since January 18, 2017 until April 01, 2023. She serves as Director at GlaxoSmithKline Capital plc since May 01, 2023. She served as the Chief Financial Officer and Director of Smith & Nephew Plc from February 4, 2013 to January 11, 2017. She was responsible for finance, Investor Relations, IT, global business services and business transformation. She gained extensive M&A and transformational past work through the merger between Astra and Zeneca and her role in Smith & Nephew. Prior to this, she worked at ICI and AstraZeneca plc from 1987. She served as an Interim Group Chief Financial Officer of AstraZeneca PLC since June 1, 2012 and served as its Vice President of Group Finance. While working with AstraZeneca (and predecessor companies), she has held a number of senior financial and management positions including Regional Vice President/Regional and Country Head of Latin America, Marketing Company President of AZ Portugal and Vice President of Corporate Strategy and Research and Development Chief Financial Officer. She worked in CFO positions in the FTSE 100 and has a strong track record of leading change and supporting businesses through her significant past work in financial, commercial and strategic roles. She serves as a Director of Tusk Therapeutics Ltd. She had been a Non-Executive Independent Director at Roche Holding AG since March 1, 2016 until September 26, 2022. She was Audit Senior at KPMG, UK from 1983 to 1987. She was R&D Finance Manager at ICI plc, UK from 1987 to 1989. She served as Vice President of Finance, Product Strategy and Licensing of AstraZeneca plc, UK from 1999 to 2002. She was Licensing and Commercial Finance Manager at ICI plc, UK from 1989 to 1992. She was Financial Controller of Pharmaceuticals, Zeneca plc, UK from 1992 to 1994. She served as Business Development Director, Zeneca plc, UK from 1994 to 1997. She served as Head of Finance Department of Zeneca plc, UK from 1997 to 1999. She served as Marketing Company President of AstraZeneca plc, Portugal from 2008 to 2010. She currently sits as a nonExecutive Director on the Board of Swiss healthcare rival Roche. She is on the Business Advisory Board to the Mayor of London. She qualified as a Chartered Accountant with KPMG and is a Fellow of the Institute of Chartered Accountancy in 1986 Fellow of Fellow of Institute of Taxation in 1987 and INSEAD Advanced Management Program, Paris in 1997. She holds honors degree, BA Social Sciences from Warwick University in 1983.

Positions